Roger Pomerantz insider trades
Open-market stock purchases and sales by Roger Pomerantz, Director at Indaptus Therapeutics, Inc, from SEC Form 4 filings since Jun 26, 2015.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- INDP Indaptus Therapeutics, Inc: other filings, last Jun 10, 2025
- VIRX Viracta Therapeutics, Inc: other filings, last Nov 25, 2024
- CFRX CONTRAFECT Corp: 2 buys, last Feb 15, 2022
- NTEC Intec Pharma Ltd: other filings, last Jul 15, 2020
- MCRB Seres Therapeutics, Inc: 49 sales, last Jun 13, 2019
- RUBY Rubius Therapeutics, Inc: 1 buy, last Jul 20, 2018